Search Result "GLP-1 Receptor Agonist"
GLP-1 Agonists and Satiety
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 8 Issue: 4 Year: 2008 Page: 311-316
Author(s): Nicholas T. Bello, Timothy H. Moran
Drug Design of GLP-1 Receptor Agonists: Importance of In Silico Methods
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 8 Year: 2021 Page: 1015-1024
Author(s): Smriti Sharma,Vinayak Bhatia
GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta
Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
Journal: Current Diabetes Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 191-200
Author(s): Danilo Verge, Ximena Lopez
Met-204 And Tyr-205 Are Together Important For Binding Glp-1 Receptor Agonists But Not Their N-Terminally Truncated Analogues
Journal: Protein & Peptide Letters
Volume: 11 Issue: 1 Year: 2004 Page: 15-22
Author(s): Rakel Lopez de Maturana, Janet Treece-Birch, Fatima Abidi, John B.C. Findlay, Dan Donnelly
The Primary Ligand-Binding Interaction At The Glp-1 Receptor Is Via The Putative Helix Of The Peptide Agonists
Journal: Protein & Peptide Letters
Volume: 11 Issue: 1 Year: 2004 Page: 9-14
Author(s): Suleiman Al-Sabah, Dan Donnelly
GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 3 Year: 2012 Page: 214-228
Author(s): Giuseppe Derosa,Pamela Maffioli
Treatment of Type 1 Diabetic Patients with Glucagon-Like Peptide-1 (GLP-1) and GLP-1R Agonists
Journal: Current Diabetes Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 266-275
Author(s): Urd Kielgast, Jens J. Holst, Sten Madsbad
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 3 Year: 2017 Page: 218-229
Author(s): Themistoklis Tzotzas,Spyridon N. Karras,Niki Katsiki
GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 36 Year: 2015 Page: 5292-5298
Author(s): Djordje S. Popovic,Edita Stokic,Stevan L. Popovic